Register

Scientific Program

IMPORTANT NOTE: Virtual meeting time indicated in the scientific program is expressed as CET Time Zone. Please check time as per your timezone

15.03.2025
 16.03.2025
15.03.2025
10:00 - 10:05
MAIN HALL

Introduction to the Symposium

Prof.Dr. Murat Akova (Turkey)
Rafael De La Camara (Spain)
15.03.2025
10:05 - 11:45
MAIN HALL

Opening Session

*Chair : Prof.Dr. Volkan Korten (Turkey)
Non-infectious causes of febrile neutropenia Abdullah Tarık Aslan (Turkey) (08:05 - 09:45)
Antimicrobial stewardship in febrile neutropenia Prof.Dr. Ömrüm Uzun (Turkey) (08:05 - 09:45)
Standardised reporting of infection events in immunocompromised patients Ben Teh (Australia) (08:05 - 09:45)
15.03.2025
11:45 - 12:15
MAIN HALL

Young Fellows’ Presentations

*Chair : Prof.Dr. Murat Akova (Turkey)
A scoring system to predict resistance to ceftolozane/ tazobactam in respiratory isolates of P. aeruginosa Eda Karadoğan
Cost effectiveness of carbapenem treatment duration in febrile neutropenia in patients with haematological malignancies Leyla Yumrukaya (Turkey)
15.03.2025
12:15 - 12:30

Break

15.03.2025
12:30 - 14:30
MAIN HALL

New ECIL-10 Guidelines: Bacterial infections and antimicrobial resistance

*Chair : Prof.Dr. Murat Akova (Turkey)
Epidemiology of antibacterial resistance Francesco Bacelli (Italy) (10:30 - 12:30)
Non-culture based diagnostics in febrile neutropenia Dionysos Neofytos (Switzerland) (10:30 - 12:30)
Empirical antibacterial therapy and duration of treatment Dina Averbuch (Israel) (10:30 - 12:30)
Targeted antibacterial therapy Yuri Vanbiervliet (Belgium) (10:30 - 12:30)
15.03.2025
14:30 - 15:30
MAIN HALL

Industry Supported Session / Management of Invasive Fungal Infection in Febrile Neutropenic Patients with Case Presentations

*Moderator : Prof.Dr. Halis Akalın (Turkey)
Özlem Tunçcan (Turkey) (12:30 - 13:30)
Uzman Dr. Recep Tekin (Turkey) (12:30 - 13:30)
15.03.2025
15:30 - 16:30
MAIN HALL

New ECIL-10 Guidelines: C. difficile infections and antifungal prophylaxis

*Chair : Malgorzata Mikulska (Italy)
C. difficile infections in hematologic malignancies Malgorzata Mikulska (Italy) (13:30 - 14:30)
Update on antifungal prohylaxis Livio Pagano (Italy) (13:30 - 14:30)
15.03.2025
16:30 - 18:00
MAIN HALL

New ECIL-10 Guidelines: CMV, COVID-19 and other viral respiratory infections

*Chair : Rafael De La Camara (Spain)
Update on community-acquired respiratory viral infections Hans H. Hirsch (Switzerland) (14:30 - 16:00)
Update on COVID-19 Simone Cesaro (Italy) (14:30 - 16:00)
Update on CMV infections Roy Fouad Chemaly (United States) (14:30 - 16:00)
15.03.2025
18:00 - 18:30
MAIN HALL

Young fellows’ presentations

*Chair : Prof.Dr. Murat Akova (Turkey)
Risk of infection in patients with hematological malignancies recieving CAR-T cell threapy: Systematic review and metanalysis Gülçin Telli Dizman (Turkey)
Therapeutic drug monitoring of meropenem in adult inpatients: A single center, retrospective study Emre Kara
15.03.2025
18:30 - 19:30
MAIN HALL

New therapeutic modalities and infectious complications

*Chair : Prof.Dr. Murat Akova (Turkey)
CAR T-cell therapy related infections Erika Kampouri (Switzerland) (16:30 - 17:30)
Summary of NCNN 2024 Guidelines: Prevention and treatment of cancer related infections Steven A. Pergam (United States) (16:30 - 17:30)
16.03.2025
10:30 - 11:30
MAIN HALL

Emerging technologies and their applications in febrile neutropenia

*Chair : Prof.Dr. Hamdi Akan (Turkey)
Decision support systems in febrile neutropenia Gökhan Metan (Turkey) (08:30 - 09:30)
The role of artifical intelligence in febrile neutropenia Ahmet Görkem Er (Turkey) (08:30 - 09:30)
16.03.2025
11:30 - 13:00
MAIN HALL

Ethics, clinical trials and febrile neutropenia

*Chair : Dafna Yahav (Israel)
Duration of antimicrobial therapy in febrile neutropenia: Ethical concerns Euzebiusz Jamrozik (Australia) (09:30 - 11:00)
Reverse isolation in febrile neutropenia: Ethical dilemmas Asma Nasim (Pakistan) (09:30 - 11:00)
Incorporation ethics into infectious disease clinical practice guidelines Elda Righi (United Kingdom) (09:30 - 11:00)
16.03.2025
13:00 - 14:00
MAIN HALL

Industry Supported Session / New Strength in the Primary Treatment of IFI: Posagil

Gökhan Metan (Turkey)
16.03.2025
14:00 - 15:00
MAIN HALL

Update on selected issues in febrile neutropenia

*Chair : Tezer Kutluk
Pediatric febrile neutropenia Thomas Lehrnbecher (Germany) (11:00 - 12:00)
Vaccination in patients with hematological cancer and hematopoietic stem cel transplantation Jon Salmanton Garcia (Germany) (11:00 - 12:00)
16.03.2025
15:00 - 16:30
MAIN HALL

What is new in fungal infections

*Chair : Prof.Dr. Sevtap Arıkan Akdağlı (Turkey)
Climate change and fungal infections Prof.Dr. Sevtap Arıkan Akdağlı (Turkey) (12:00 - 13:30)
Fungal infections in the ICU Matteo Bassetti (Italy) (12:00 - 13:30)
Update on new antifungals Martin Hönigl (Austria) (12:00 - 13:30)
16.03.2025
16:30 - 17:30
MAIN HALL

Young fellows’ presentation

*Chair : Prof.Dr. Murat Akova (Turkey)
Impact of Aspergillus PCR on the management of invasive aspergillosis: A tertiary care hospital experience during the COVID-19 pandemic Muhammed Cihan Işık
Coexistance of invasive pulmonary aspergillosis and nocardiosis in an immunosuppressed patient Emine Dinç (Turkey)
Nilüfer Aylin Öztürk
Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience Nilüfer Aylin Öztürk
The role of clinical pharmacist in the management of antibacterial prophylaxis in neutropenia patients with cancer Elif Aras
16.03.2025
17:30 - 17:40
MAIN HALL

Closing

© 2021 Serenas Group All Rights Reserved
Information Statement
Help
Contact
Cookies

Mandatory and functional cookies are used on this website, due to their necessity for our website to function properly, to navigate its content and to benefit from its features. You can disable these cookies at any time in your browser settings.Disabling cookies may cause all or some of our website's features to become unavailable. For more information about how we use cookies, you can visit our Cookie Policy. Do you accept the processing of your data via marketing cookies ?

Accept All Cookies